Sanne de Bruin

51 Transfusion practice in the non-bleeding critically ill; an international online survey – The TRACE Survey cell concentrates in anemic critically ill patients with iron deficiency? (multiple answers possible) a. Iron suppletion b. Erythropoietin (epo) suppletion c. Iron suppletion in combination with erythropoietin (epo) d. None of the above e. Other, please specify 26. Which measures are available in your ICU to minimize the amount of red cell concentrate transfusion? (multiple answers possible) a. Closed loop sampling b. Computer decision making program c. Microtube sampling d. None e. Other, please specify Platelets 27. What is your threshold for prophylactic platelet transfusion in thrombocytopenic non-bleeding patients on the ICU (thus not prior to an invasive procedure)? (10^9 cells/L) 28. What is your threshold for platelet trans- fusion in non-bleeding thrombocytopenic patients prior to placing a central line on the ICU? (10^9 cells/L) 29. What is your threshold for platelet transfu- sion in critically ill non-bleeding throm- bocytopenic patients prior to a tracheoto- my? (10^9 cells/L) 30. What is your threshold for platelet trans- fusion in thrombocytopenic non-bleeding critically ill patients prior to neurosurgery? (10^9 cells/L) 31. What is your threshold for platelet trans- fusion in thrombocytopenic non-bleeding critically ill patients on the ICU prior to general surgery? (10^9 cells/L) 32. Do you check thrombocyte count after transfusion of one unit thrombocyte concentrate (1 unit is approx. 300 x 10^9 platelets) before transfusing a second unit in non-bleeding critically ill patients? a. Always b. Most of the time c. Sometimes d. Never Plasma 33. Which coagulation tests are available as standard care on your ICU? (multiple answers possible) a. PT/INR b. aPTT c. Fibrinogen d. Rotational thromboelastometry (ROTEM) e. Thromboelastography (TEG) f. Other, please specify 34. Do you check the INR after transfusion of one unit of plasma before transfusing a second unit in a non-bleeding patient with plasmatic coagulopathy (INR>3.0) who used vitamin K antagonists? a. Always b. Most of the time c. Sometimes d. Never e. Not applicable 2